Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2022-08-03 Capital/Financing Update
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Proposed issue of securities - MVP 15 pages 53.9KB
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding a proposed issue of securities by Medical Developments International Limited. It includes specifics about the types of securities to be issued, offer prices, dates for trading and record, underwriting details, and fees related to the offer. The content focuses on the company's capital raising activities through an accelerated offer and entitlement issue. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is clearly an update on financing activities and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a simple notice but a substantive update on a capital raising event.
2022-08-03 English
Update - Proposed issue of securities - MVP 14 pages 52.2KB
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding a proposed issue of securities by Medical Developments International Limited. It includes specifics about the type of securities, offer price, underwriting details, timetable, and other related information. The content focuses on the company's capital raising activities, including an accelerated non-renounceable entitlement offer and options issuance. There is no indication that this is a full financial report, audit report, or earnings release. Instead, it is an update and detailed disclosure about a capital raising event, which fits the category of Capital/Financing Update filings. The document is lengthy (15,000 characters) and contains substantive details about the financing, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-08-03 English
Appointment of General Counsel and Company Secretary 2 pages 188.0KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 30 May 2022 regarding the appointment of a new General Counsel and Company Secretary. It contains no financial data, no report or presentation, and no mention of voting results or regulatory filings beyond the announcement itself. The content focuses solely on management changes at the company. The document length is 3596 characters, which is relatively short and typical for a management change announcement. Therefore, the document fits best under the category of Board/Management Information (MANG).
2022-05-29 English
Notification of cessation of securities - MVP 4 pages 24.2KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of securities, specifically options that have lapsed due to conditions not being met. It provides details about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement related to changes in the company's securities, not a financial report or detailed analysis. It does not contain financial statements or management discussion, nor is it a report publication or certification. This type of announcement fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-05-25 English
MVP signs new Penthrox licensing agreement in Canada 2 pages 187.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 10 May 2022 about Medical Developments International signing a new licensing agreement for Penthrox in Canada. It is a corporate update regarding a new partnership and distribution rights, not a financial report, earnings release, or regulatory filing. The content focuses on a business development related to licensing and commercial activities, which fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes. The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2022-05-09 English
Chief Financial Officer Transition 2 pages 161.9KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated May 5, 2022, regarding the resignation of the Chief Financial Officer and Company Secretary and the appointment of a successor. It contains no financial statements, no detailed financial data, no regulatory certifications, or report attachments. The content focuses solely on management changes at the executive level. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (2591 characters), and it is clearly an announcement rather than a full report or filing.
2022-05-04 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.